These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 7405849)
1. Drug interactions and antiplatelet agents. Ahmad S Am J Cardiol; 1980 Aug; 46(2):341. PubMed ID: 7405849 [No Abstract] [Full Text] [Related]
2. On the inhibiting effect of sulfinpyrazone on platelets. Cortellaro M; Polli EE Thromb Res; 1979; 15(5-6):895-6. PubMed ID: 494186 [No Abstract] [Full Text] [Related]
4. Effect of drugs of platelets and complications of vascular disease. Mustard JF; Packham MA; Kinlough-Rathbone RL Adv Exp Med Biol; 1977; 82():94-105. PubMed ID: 920448 [No Abstract] [Full Text] [Related]
5. Mode of action of currently used antiplatelet drugs. de Gaetano G; Bertele' V; Cerletti C Agents Actions Suppl; 1986; 20():191-201. PubMed ID: 3101442 [No Abstract] [Full Text] [Related]
6. [Influence of Anturane on platelets aggregation. Comparative study with acetylsalicylic acid in patients with and without oral anticoagulant therapy]. Fernández B de Quirós J; Dulp-Gollasch I; Hess H Rev Clin Esp; 1978 Nov; 151(3):219-22. PubMed ID: 740996 [No Abstract] [Full Text] [Related]
7. [The pharmacology of sulfinpyrazone (Anturan)]. Rüegg M Wien Med Wochenschr Suppl; 1980; 61():3-8. PubMed ID: 6930768 [No Abstract] [Full Text] [Related]
8. Pharmacology of antiplatelet drugs and clinical trials on thrombosis prevention: a difficult link. de Gaetano G; Cerletti C; Bertelè V Lancet; 1982 Oct; 2(8305):974-7. PubMed ID: 6127469 [No Abstract] [Full Text] [Related]
9. Status of antiplatelet drugs in coronary heart disease. Mehta J; Mehta P JAMA; 1979 Jun; 241(24):2649-51. PubMed ID: 439365 [No Abstract] [Full Text] [Related]
10. Sulfinpyrazone: relationship between dose, kinetics, plasma concentrations and biological effects. Buchanan MR Thromb Res Suppl; 1983; 4():89-92. PubMed ID: 6356467 [No Abstract] [Full Text] [Related]
15. Letter: Action of sulfinpyrazon. de Jonge H; Loeliger EA Thromb Diath Haemorrh; 1975 Jun; 33(3):674. PubMed ID: 1154325 [No Abstract] [Full Text] [Related]
16. [Current clinical results of antiplatelet medication]. Ordinas A Sangre (Barc); 1984; 29(4-C):833-40. PubMed ID: 6393391 [No Abstract] [Full Text] [Related]
17. The effect of sulfinpyrazone on platelet and pulmonary responses to onset of membrane oxygenator perfusion. Birek A; Duffin J; Glynn MF; Cooper JD Trans Am Soc Artif Intern Organs; 1976; 22():94-101. PubMed ID: 951897 [No Abstract] [Full Text] [Related]
18. Effects of sulfinpyrazone on platelet prostaglandin synthesis and platelet release of serotonin. Ali M; McDonald JW J Lab Clin Med; 1977 Apr; 89(4):868-75. PubMed ID: 845486 [TBL] [Abstract][Full Text] [Related]
19. Antiplatelet therapy (first of two parts). Weiss HJ N Engl J Med; 1978 Jun; 298(24):1344-7. PubMed ID: 651993 [No Abstract] [Full Text] [Related]
20. [Effect of sulfinpyrazone on the platelet function and in experimental thrombosis]. Haas S; Ketterl R; Blümel G Fortschr Med; 1981 Jan; 99(4):113-8. PubMed ID: 7274948 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]